Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06642610 · ClinicalTrials.gov registry record · NA
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
A NA study of PreDiabetes and Cystic Fibrosis (CF), sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06642610: Recruiting NA study of PreDiabetes and Cystic Fibrosis (CF), sponsored by Indiana University.
NCT06642610 is a NA study of PreDiabetes and Cystic Fibrosis (CF) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 70 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06642610, a NA study of PreDiabetes and Cystic Fibrosis (CF), is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Primary Outcome
Estimating the "optimal" cut-offs of the CDI marker, to distinguish between CF groups
Conditions Studied
Interventions
- DEVICE CGM Dynamic Index (CDI)
Study Locations (1)
Indiana
- Indiana University Health, University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-06-15 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06642610 shows while recruiting
NCT06642610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (90% lower).
The record links to 3 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM Dynamic Index (CDI) is the first listed.
NCT06642610 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06642610 about?
NCT06642610 is a clinical study titled "CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis". The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
What is the current status of trial NCT06642610?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-06-15. Estimated completion is 2026-06-30.
What conditions does trial NCT06642610 study?
This clinical trial studies the following conditions: PreDiabetes, Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes.
What interventions are being tested in trial NCT06642610?
The interventions under investigation include: CGM Dynamic Index (CDI) (DEVICE).
Who is sponsoring clinical trial NCT06642610?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06642610 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06642610's enrollment target sits among peer trials
70 79th of 149 higher than 68 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI